Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULARStandard

SIGNIFOR LAR KIT

PASIREOTIDE PAMOATE

Standard Dose
EQ 20MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SIGNIFOR LAR KIT is listed in Drugs@FDA under application 203255 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PASIREOTIDE PAMOATE Form and strength FOR SUSPENSION;INTRAMUSCULAR - EQ 20MG BASE/VIAL Sponsor RECORDATI RARE Submission history Latest submission status date: 2024-07-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview SIGNIFOR LAR KIT is listed in Drugs@FDA under application 203255 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PASIREOTIDE PAMOATE Form and strength FOR SUSPENSION;INTRAMUSCULAR - EQ 20MG BASE/VIAL Sponsor RECORDATI RARE Submission history Latest submission status date: 2024-07-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.